[
    [
        {
            "time": "",
            "original_text": "【民生医药|专题】Laborcorp 2019年年报梳理：药物开发业务稳健增长，持续并购强化实力",
            "features": {
                "keywords": [
                    "Laborcorp",
                    "2019年年报",
                    "药物开发",
                    "稳健增长",
                    "持续并购",
                    "强化实力"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【民生医药|专题】Laborcorp 2019年年报梳理：药物开发业务稳健增长，持续并购强化实力",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]